Pursuant Health Closes $12.8M Series A1 Funding

Pursuant_HealthPursuant Health (formerly known as SoloHealth), an Atlanta, Georgia — based provider of a consumer health engagement and data collection platform, closed a $12.8m Series A1 funding.

The round included the conversion of previous debt financings to equity.

The company will use the funds to add new channels to its population health platform including texting, mobile, digital and incentive management capabilities, providing broader program administration, engagement and collection of health data.

Led by Larry Gerdes, CEO, Pursuant Health provides a platform that couples behavioral economics with real-time incentives and adaptive logic to engage individuals to manage their health and improve outcomes.
By utilizing multi-channel communication strategies, convenient care settings and real-time incentive management capabilities, the platform engages a wide range of at-risk, historically hard-to-reach members. The platform consists of multiple channels, including a kiosk network of over 3,600 FDA-cleared, HIPAA-compliant self-service medical devices located within 10 miles of 79% of the U.S. population.



Join the discussion